{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T05:47:31Z","timestamp":1724824051291},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNRD"],"DOI":"10.2147\/ijnrd.s149877","type":"journal-article","created":{"date-parts":[[2018,1,14]],"date-time":"2018-01-14T21:13:54Z","timestamp":1515964434000},"page":"25-32","source":"Crossref","is-referenced-by-count":3,"title":["Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial"],"prefix":"10.2147","volume":"Volume 11","author":[{"given":"Osama","family":"Sawalmeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaheed","family":"Moala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakaria","family":"Hamdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Masri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khubaib","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Khazneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujahed","family":"Shraim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,1]]},"container-title":["International Journal of Nephrology and Renovascular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=40127","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=40127","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,14]],"date-time":"2018-01-14T21:13:55Z","timestamp":1515964435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/pulse-versus-daily-oral-alfacalcidol-treatment-of-secondary-hyperparat-peer-reviewed-article-IJNRD"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ijnrd.s149877","relation":{},"ISSN":["1178-7058"],"issn-type":[{"value":"1178-7058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}